Literature DB >> 31813079

Determination of pentraxin 3 levels in cerebrospinal fluid during central nervous system infections.

Marta Zatta1, Stefano Di Bella2, Barbara Bottazzi3, Francesca Rossi4, Pierlanfranco D'Agaro5, Ludovica Segat5, Massimiliano Fabbiani6, Alberto Mantovani3, Roberto Luzzati2.   

Abstract

Pentraxin 3 (PTX3) is an acute phase protein; its plasmatic levels significantly rise during severe infections. Data on PTX3 levels in cerebrospinal fluid (CSF) of patients with central nervous system (CNS) infections are lacking. We aimed (a) to assess the diagnostic potential of measuring CSF PTX3 levels in patients with CNS infections and (b) to establish CSF PTX3 cutoffs to distinguish between bacterial and aseptic meningoencephalitis (ROC curve). PTX3 levels were measured in CSF from 19 patients admitted to Trieste Hospital, Italy, with CNS infection. A diagnosis of bacterial infection and aseptic meningoencephalitis was made in 7 (37%) and 12 (63%) patients, respectively. Subjects with bacterial infections showed significantly higher PTX3 levels (13.5 vs 1.27 ng/mL in aseptic meningoencephalitis, p = 0.010). We identified two different CSF PTX3 levels cutoffs. (1) The best cutoff to maximise Youden's J was 9.6 ng/mL with a sensitivity, specificity, positive predictive value and negative predictive value (NPV) of 71.4%, 91.4%, 83.3%, 84.6%, respectively. (2) The cutoff with higher NPV (100%) was 3.6 ng/mL; a diagnosis of bacterial infections was obtained in 0% patients with CSF PTX3 levels < 3.6 ng/mL vs 58% of those with CSF PTX3 levels ≥ 3.6 ng/mL (p = 0.017). CSF PTX3 levels are higher in bacterial meningitis than aseptic meningoencephalitis. A cutoff of 3.6 ng/mL of CSF PTX3 has a high NPV and can be used to exclude bacterial CNS infections.

Entities:  

Keywords:  Central nervous system infections; Etiology; Meningitis; Pentraxin3

Year:  2019        PMID: 31813079     DOI: 10.1007/s10096-019-03767-w

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  ESCMID guideline: diagnosis and treatment of acute bacterial meningitis.

Authors:  D van de Beek; C Cabellos; O Dzupova; S Esposito; M Klein; A T Kloek; S L Leib; B Mourvillier; C Ostergaard; P Pagliano; H W Pfister; R C Read; O Resat Sipahi; M C Brouwer
Journal:  Clin Microbiol Infect       Date:  2016-04-07       Impact factor: 8.067

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Inducible expression of the long pentraxin PTX3 in the central nervous system.

Authors:  N Polentarutti; B Bottazzi; E Di Santo; E Blasi; D Agnello; P Ghezzi; M Introna; T Bartfai; G Richards; A Mantovani
Journal:  J Neuroimmunol       Date:  2000-07-01       Impact factor: 3.478

5.  The acute-phase protein PTX3 is an essential mediator of glial scar formation and resolution of brain edema after ischemic injury.

Authors:  Beatriz Rodriguez-Grande; Matimba Swana; Loan Nguyen; Pavlos Englezou; Samaneh Maysami; Stuart M Allan; Nancy J Rothwell; Cecilia Garlanda; Adam Denes; Emmanuel Pinteaux
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-18       Impact factor: 6.200

6.  Pentraxin 3 and C-reactive protein in severe meningococcal disease.

Authors:  Tom Sprong; Giuseppe Peri; Chris Neeleman; Alberto Mantovani; Stefano Signorini; Jos W M van der Meer; Marcel van Deuren
Journal:  Shock       Date:  2009-01       Impact factor: 3.454

Review 7.  Pentraxins as a key component of innate immunity.

Authors:  Barbara Bottazzi; Cecilia Garlanda; Giovanni Salvatori; Pascale Jeannin; Angelo Manfredi; Alberto Mantovani
Journal:  Curr Opin Immunol       Date:  2005-12-15       Impact factor: 7.486

Review 8.  Pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection.

Authors:  Siguan Liu; Xin Qu; Feng Liu; Chunting Wang
Journal:  Mediators Inflamm       Date:  2014-11-03       Impact factor: 4.711

9.  Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with sepsis and septic shock.

Authors:  Chenggong Hu; Yongfang Zhou; Chang Liu; Yan Kang
Journal:  Oncotarget       Date:  2017-12-26

10.  The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps.

Authors:  Sébastien Jaillon; Giuseppe Peri; Yves Delneste; Isabelle Frémaux; Andrea Doni; Federica Moalli; Cecilia Garlanda; Luigina Romani; Hugues Gascan; Silvia Bellocchio; Silvia Bozza; Marco A Cassatella; Pascale Jeannin; Alberto Mantovani
Journal:  J Exp Med       Date:  2007-03-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.